CYAD
COM:CELYAD
Celyad Oncology
- Stock
0.53
−3.28%
−0.02
Last Close
0.55
31/03 15:35
Market Cap
11.14M
Beta: -
Volume Today
13.66K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.00 - | 0.00 99.43% | 0.06 326,408.79% | 0.05 25.73% | 0.03 27.56% | 0.00 99.80% | 0.00 13.29% | 0.01 - | |||
cash conversion cycle | -5.64K - | 78.96K 1,500.29% | -55.71K 170.56% | -3.38K 93.94% | 3.14K - | ||||||
cash per share | 4.49 - | 12.67 182.15% | 8.85 30.12% | 3.52 60.20% | 4.47 26.74% | 3.14 29.65% | 1.24 60.65% | 1.92 55.63% | 0.55 71.37% | ||
company equity multiplier | 1.65 - | 1.43 13.17% | 1.53 6.72% | 1.63 6.92% | 1.70 3.87% | 1.97 16.09% | 2.13 8.27% | 1.83 14.08% | 4.57 149.31% | 2.58 43.45% | |
days of inventory outstanding | 2.90K - | ||||||||||
days of payables outstanding | 12.83K - | 490.48 96.18% | 55.77K 11,270.35% | 3.40K 93.90% | 6.58K - | ||||||
days of sales outstanding | 4.29K - | 79.45K 1,750.86% | 58.20 99.93% | 24.02 58.72% | 43.00 79.00% | 164.37K 382,131.15% | 66.21K 59.72% | 9.72K - | |||
dividend yield | |||||||||||
ebit per revenue | -112.58 - | -9.89K 8,685.29% | -3.00 99.97% | -14.94 397.11% | -12.25 17.96% | -4.90K 39,851.49% | -5.25K 7.20% | -103.89 - | |||
ebt per ebit | 1.00 - | 0.98 1.98% | 0.92 6.03% | 1.07 15.68% | 0.98 8.07% | 0.98 0.56% | 0.66 32.76% | 1.00 53.16% | 1.00 0.39% | 0.80 19.71% | |
effective tax rate | 0.15 - | 0.00 98.75% | 0.00 86.55% | 0.00 93.02% | 0.03 167,760.49% | 0.00 99.06% | -0.02 6,280.31% | -0.00 97.81% | -0.00 321.49% | 0.01 565.43% | |
enterprise value multiple | -11.17 - | -11.28 0.99% | -5.45 51.70% | -18.60 241.33% | -3.90 79.01% | -3.15 19.30% | -3.25 3.24% | -1.07 67.00% | 0.04 103.75% | 0.56 1,293.46% | |
fixed asset turnover | 0.24 - | 0.00 98.92% | 2.39 90,480.30% | 1.08 55.02% | 1.03 3.95% | 0.00 99.89% | 0.00 2.39% | 0.06 - | |||
free cash flow per share | -2.67 - | -3.32 23.96% | -2.84 14.42% | -5.24 84.60% | -2.60 50.27% | -2.30 11.64% | -2.01 12.80% | -1.73 13.68% | -1.25 28.13% | ||
gross profit margin | 0.21 - | -2.13K 1,001,534.41% | 0.99 100.05% | 0.85 14.01% | 1 17.02% | 1 0% | 1 0% | 0.32 - | |||
interest coverage | -747.14 - | -125.73 83.17% | -123.71 1.60% | -11.87 90.40% | -615.65 5,085.88% | -85.64 86.09% | -88.35 3.17% | -103.49 17.15% | -207.40 100.39% | -126.15 39.17% | |
inventory turnover | 0.13 - | ||||||||||
long term debt to capitalization | 0.01 - | 0.00 63.12% | 0.01 161.77% | 0.02 67.32% | 0.02 6.66% | 0.06 296.02% | 0.08 21.93% | 0.04 49.38% | 0.03 30.22% | ||
net income per ebt | 1 - | 1 0% | 1.00 0.03% | 1.00 0.02% | 0.97 2.97% | 1.00 3.04% | 1.02 1.75% | 1.00 1.66% | 1.00 0.12% | 0.99 0.90% | |
net profit margin | -112.69 - | -9.70K 8,511.69% | -2.77 99.97% | -15.93 475.18% | -11.66 26.82% | -4.77K 40,835.15% | -3.50K 26.65% | -82.82 - | |||
operating cash flow per share | -2.58 - | -3.22 24.69% | -2.65 17.73% | -5.15 94.55% | -2.45 52.49% | -2.25 7.94% | -1.98 11.89% | -1.71 13.95% | -1.24 27.39% | ||
operating cycle | 7.19K - | 79.45K 1,004.94% | 58.20 99.93% | 24.02 58.72% | 9.72K - | ||||||
operating profit margin | -112.58 - | -9.89K 8,685.29% | -3.00 99.97% | -14.94 397.11% | -12.25 17.96% | -4.90K 39,851.49% | -5.25K 7.20% | -103.89 - | |||
payables turnover | 0.03 - | 0.74 2,515.59% | 0.01 99.12% | 0.11 1,539.34% | 0.06 - | ||||||
pretax profit margin | -112.69 - | -9.70K 8,511.69% | -2.77 99.97% | -15.93 475.05% | -12.02 24.58% | -4.77K 39,627.83% | -3.44K 27.92% | -83.44 - | |||
price fair value | 8.58 - | 3.71 56.72% | 1.83 50.73% | 6.98 281.78% | 3.32 52.38% | 2.66 19.90% | 2.98 11.83% | 1.26 57.79% | 2.65 110.70% | ||
receivables turnover | 0.09 - | 0.00 94.60% | 6.27 136,410.15% | 15.19 142.26% | 8.49 44.13% | 0.00 99.97% | 0.01 148.25% | 0.04 - | |||
return on assets | -0.37 - | -0.18 51.22% | -0.17 6.82% | -0.73 327.19% | -0.39 46.99% | -0.32 17.24% | -0.26 16.91% | -0.33 25.23% | -2.08 526.06% | -0.52 75.01% | |
return on capital employed | -0.43 - | -0.20 53.76% | -0.20 0.18% | -0.76 277.89% | -0.45 40.58% | -0.38 16.39% | -0.48 28.30% | -0.40 17.47% | -4.40 1,001.80% | -0.79 81.95% | |
return on equity | -0.62 - | -0.26 57.64% | -0.26 0.55% | -1.19 356.76% | -0.65 44.94% | -0.63 3.92% | -0.56 10.03% | -0.61 7.59% | -9.48 1,460.79% | -1.34 85.87% | |
total debt to capitalization | 0.02 - | 0.01 60.51% | 0.02 165.87% | 0.03 84.24% | 0.03 2.46% | 0.09 203.54% | 0.11 20.34% | 0.06 45.85% | 0.06 1.95% | 0.02 56.70% |
All numbers in EUR (except ratios and percentages)